EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 308 filers reported holding EXELIXIS INC in Q2 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $215,000 | +0.5% | 10,181 | -13.3% | 0.01% | 0.0% |
| Q2 2021 | $214,000 | -18.9% | 11,747 | +0.4% | 0.01% | -33.3% |
| Q1 2021 | $264,000 | +12.3% | 11,700 | 0.0% | 0.02% | -28.6% |
| Q4 2020 | $235,000 | -13.3% | 11,700 | +5.6% | 0.02% | -19.2% |
| Q3 2020 | $271,000 | +0.7% | 11,080 | -2.4% | 0.03% | +4.0% |
| Q2 2020 | $269,000 | -58.7% | 11,348 | -62.8% | 0.02% | -62.1% |
| Q2 2019 | $652,000 | -23.3% | 30,514 | -14.5% | 0.07% | -27.5% |
| Q1 2019 | $850,000 | +31.6% | 35,704 | +8.7% | 0.09% | +9.6% |
| Q4 2018 | $646,000 | -20.9% | 32,850 | -28.7% | 0.08% | -10.8% |
| Q3 2018 | $817,000 | -5.3% | 46,101 | +14.9% | 0.09% | -13.1% |
| Q2 2018 | $863,000 | +174.0% | 40,108 | +182.2% | 0.11% | +161.0% |
| Q1 2018 | $315,000 | +1650.0% | 14,215 | +23.4% | 0.04% | +1266.7% |
| Q3 2014 | $18,000 | – | 11,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 17,416,738 | $422,007,000 | 64.06% |
| Matrix Capital Management Company, LP | 15,117,460 | $366,296,000 | 11.71% |
| Rhenman & Partners Asset Management AB | 1,050,000 | $25,442,000 | 3.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 254,334 | $6,163,000 | 2.40% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 790,148 | $19,145,000 | 1.30% |
| Jupiter Investment Management Ltd | 4,182,760 | $101,348,000 | 1.06% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 50,818 | $1,231,000 | 0.70% |
| C M BIDWELL & ASSOCIATES LTD | 17,475 | $423,000 | 0.65% |
| QCM Cayman, Ltd. | 9,562 | $232,000 | 0.60% |
| Handelsinvest Investeringsforvaltning | 98,500 | $2,387,000 | 0.56% |